Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    FP05 - Mesothelioma, Thymoma and Other Thoracic Malignancies

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Type: Posters (Featured)
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    • +

      FP05.04 - Outcomes of Resected Thymic Epithelial Tumors (TET), insights from RYTHMIC

      00:00 - 00:00  |  Presenter: Jose Carlos Benitez

      • Abstract

      Loading...

  • +

    FP07 - Pathology

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Type: Posters (Featured)
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      FP07.12 - Underdiagnosis of EGFR Exon 20 Insertion Mutation Variants: Estimates from NGS-based Real-World Datasets

      00:00 - 00:00  |  Presenter: Joshua M. Bauml

      • Abstract

      Loading...

  • +

    P84 - Targeted Therapy - Clinically Focused - ALK

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Targeted Therapy - Clinically Focused
    • +

      P84.06 - Alectinib in ALK-Rearranged NSCLC Patients Following Crizotinib. Final Results and Biological Outcomes - Phase II ATALK Study

      00:00 - 00:00  |  Presenter: Alexis Cortot

      • Abstract

      Loading...

  • +

    OA04 - New Data from Rare EGFR Alterations

    • 11:45 - 12:45
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Targeted Therapy - Clinically Focused
    • +

      OA04.04 - Amivantamab in Post-platinum EGFR Exon 20 Insertion Mutant Non-small Cell Lung Cancer

      11:55 - 12:05  |  Presenter: Joshua K. Sabari

      • Abstract

      Loading...

  • +

    IS10 - Industry Symposium Sponsored by Bristol Myers Squibb: Thoracic Cancers, New Developments with IO

    • 13:00 - 14:00
    • 1/29/2021
    • Location: Industry Symposia Auditorium (via Industry Hub)
    • Not for CME Credit
    • Type: Industry Symposium
    • Track:
    • +

      IS10.05 - What Is I-O’s Impact on the Treatment Paradigm for Mesothelioma Patients?

      13:40 - 13:55  |  Presenter: Nicolas Girard

      • Abstract

      No abstract available for this presentation

    • +

      IS10.06 - Mesothelioma Q&A and Closing Remarks

      13:55 - 14:00  |  Presenter: Nicolas Girard, Virginie Westeel

      • Abstract

      No abstract available for this presentation

  • +

    MA04 - Health Policy and the Real World

    • 16:45 - 17:45
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Health Services Research/Health Economics
    • +

      MA04.07 - Comparative Clinical Outcomes for Patients with NSCLC Harboring EGFR Exon 20 Insertion Mutations and Common EGFR Mutations

      17:20 - 17:25  |  Presenter: Nicolas Girard

      • Abstract

      Loading...

  • +

    OA09 - Mesothelioma from Pathogenesis to Therapy

    • 15:30 - 16:30
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    • +

      OA09.03 - MESOMICS Project: Molecular Characterization of Malignant Pleural Mesothelioma Using a Multi-Omic Approach

      15:30 - 15:40  |  Presenter: Lise Mangiante

      • Abstract

      Loading...